Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)

SHE:002294 Revenue

Shenzhen Salubris Pharmaceuticals had revenue of 1.11B CNY in the quarter ending September 30, 2025, with 15.85% growth. This brings the company's revenue in the last twelve months to 4.25B, up 8.76% year-over-year. In the year 2024, Shenzhen Salubris Pharmaceuticals had annual revenue of 4.01B with 19.22% growth.

• Revenue (ttm): 4.25B
• Revenue Growth: +8.76%
• P/S Ratio: 15.86
• Revenue / Employee: 1.18M
• Employees: 3,596
• Market Cap: 67.45B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	4.01B	646.89M	19.22%
Dec 31, 2023	3.37B	-116.67M	-3.35%
Jan 1, 2023	3.48B	423.62M	13.85%
Jan 1, 2022	3.06B	319.83M	11.68%
Dec 31, 2020	2.74B	-1.73B	-38.74%